ADENOCARCINOMA OF THE STOMACH OR GASTROESOPHAGEAL JUNCTION

Clinical trials for ADENOCARCINOMA OF THE STOMACH OR GASTROESOPHAGEAL JUNCTION explained in plain language.

Never miss a new study

Get alerted when new ADENOCARCINOMA OF THE STOMACH OR GASTROESOPHAGEAL JUNCTION trials appear

Sign up with your email to follow new studies for ADENOCARCINOMA OF THE STOMACH OR GASTROESOPHAGEAL JUNCTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

New combo therapy aims to tackle Hard-to-Treat cancers

Disease control Not yet recruiting

This study tests a new drug called CVL006 combined with standard chemotherapy or other targeted drugs in people with advanced solid tumors that have not responded to previous treatments. The trial has two phases: first, to find the safest dose, and second, to see if the combinati…

Matched conditions: ADENOCARCINOMA OF THE STOMACH OR GASTROESOPHAGEAL JUNCTION

Phase: PHASE1, PHASE2 • Sponsor: Convalife (Shanghai) Co., Ltd. • Aim: Disease control

Last updated Jun 26, 2026 14:20 UTC

ADENOCARCINOMA OF THE STOMACH OR GASTROESOPHAGEAL JUNCTION

Get alerted when new ADENOCARCINOMA OF THE STOMACH OR GASTROESOPHAGEAL JUNCTION trials appear

New combo therapy aims to tackle Hard-to-Treat cancers